JAZZ PHARMACEUTICALS PLC (JAZZ)

Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of a new independent director, Laura Hamill, to its Board of Directors. Ms....

Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails

The companies are no longer developing their drug for essential tremor treatment.

Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz Pharmaceuticals") today announced that it has completed a repricing of the approximately $2.7...

If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names

Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July.

Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 second quarter financial results on Wednesday, July 31,...

Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been...

3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential

Large cap stocks are where the alpha is now, but there’s a case to be made for these undervalued mid-cap growth stocks

7 Biotech Stocks to Boost Your Portfolio to Peak Health

With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.

3 Cannabis Stocks That Could Make Your Grandchildren Rich

These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today.

Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure

The companies are working on treatments for essential tremor, a tricky indication.

Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 2b clinical trial (NCT05122650) evaluating the efficacy...

3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition

These blue-chip stocks offer stability, sustainable growth and operational models less prone to wider economic fluctuations.

7 Overlooked Stocks Offering Long-Term Stability From the Shadows

These overlooked stocks offer price appreciation, income, and more while diversifying across sectors and company sizes.

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings,...

Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that thirteen abstracts, including five late-breaking abstracts, featuring new data...

Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences:...

Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority...

3 Cannabis Stocks to Buy Now: May 2024

These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives.

7 Blue-Chip Stocks to Buy Now: May 2024

These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability.

Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through...

3 Cheap Blue-Chip Stocks to Buy Now: May 2024

If stock market speculation isn't quite working in your favor, these cheap blue-chip stocks may be the boost your portfolio needs.

Jazz Pharmaceuticals Larger Than S&P 500 Component Invesco

7 Cannabis Stocks to Buy for a Smoking-Hot 2024

Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts.

The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?

These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes.

JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

JAZZ stock results show that Jazz Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Jazz Pharmaceuticals (NASDAQ:JAZZ) just reported results for the first quarter ...

Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care...

Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2024 and affirmed guidance for 2024....

Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at...